查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840702

神經血管導管市場按產品類型、材料、尺寸、應用和最終用戶分類－2025-2032年全球預測

Neurovascular Catheters Market by Product Type, Material, Size, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，神經血管導管市場規模將達到 124.5 億美元，複合年成長率為 12.36%。

主要市場統計數據
基準年 2024 49億美元
預計年份：2025年 55.1億美元
預測年份：2032年 124.5億美元
複合年成長率 (%) 12.36%

本文建構了一個框架，闡述神經血管導管在現代血管內治療中的關鍵作用，以及影響這一領域的臨床、技術和採購壓力的匯聚。

神經血管導管在介入性神經病學、血管內治療和急性中風治療的交叉領域中發揮著至關重要的作用。這些導管便於進入、導航和輸送腦血管內的治療藥物和植入，從而能夠開展從診斷性血管造影術到複雜動脈瘤修復和血栓切除等一系列手術。近年來，微導管工程、導管尖端設計改進以及新材料的研發取得了顯著進展，大大提高了導管的輸送性和臨床精準度，縮短了手術時間，並擴大了可治療的病變範圍。隨著臨床醫生追求更微創的治療方法並不斷拓展適應症，導管的性能特徵，例如循跡性、扭矩響應和管腔完整性，變得至關重要。

臨床路徑和醫院系統日益圍繞著針對急性神經血管事件的快速、通訊協定干涉措施而構建，更加重視能夠在緊急情況下快速介入並可靠運行的醫療器械。同時，器械創新、監管以及主導方主導的品質指標的整合正在重塑採購重點和供應商關係。因此，製造商和醫療系統必須在創新與可製造性、滅菌相容性和供應穩定性之間取得平衡。在這種動態環境下，對於研發、臨床領導和商業營運等相關人員，精準理解產品差異化、材料權衡和營運流程要求至關重要。

該採納為後續章節建立了一個概念框架，重點強調了技術促進因素、臨床需求和系統層面的壓力，這些因素為設備設計師、醫院供應負責人和政策相關人員的策略決策提供了依據。

了解影響神經血管導管設計、應用動態和供應商提案主張的關鍵技術、臨床和監管變革。

神經血管導管領域正經歷多項變革，這些變革的驅動力包括技術進步、手術流程標準化以及不斷變化的醫療保險報銷預期。工程師們正致力於研發兼具柔韌性和柱強度的混合結構，從而實現長距離、曲折的導管導航，同時又不影響器械輸送的支撐力。同時，諸如血流導向裝置和專用栓塞劑等輔助器械的普及，正在改變導管的功能需求，並催生出對差異化微導管的需求，這些微導管需針對新興治療方法進行最佳化。

臨床診療流程正朝著規範化中風和動脈瘤管理的方向發展，優先選擇能夠最大限度縮短設定和更換時間的器械。這項轉變促使製造商最佳化輸送系統，以實現更快的介入、減少器械更換次數，並提升透視功能，從而實現更有效率的透視控制。法律規範也不斷加強，涵蓋上市後監控和產品可追溯性，鼓勵企業投資於品質系統和資料收集機制，以展現產品在實際應用中的效能和安全性。在財務方面，醫療系統越來越重視手術總成本和療效指標，這促使供應商在強調單價以外的提案主張時，更加注重器械的可靠性、降低併發症發生率以及對打包式醫療模式的支持。

總而言之，這些轉變塑造了一種新的格局：衡量創新的標準不僅在於技術新穎性，更在於展現其臨床和營運影響。能夠將材料科學的進步與明確的臨床效用和穩健的供應鏈結合的供應商，將更有能力影響產品應用管道和長期臨床實踐模式。

評估美國在2025年實施關稅調整將如何改變整個供應鏈的籌資策略、生產地點和競爭動態。

美國2025年關稅政策的調整對依賴複雜多層供應鏈的製造商、經銷商和醫院採購機構而言，曲折點。某些醫療組件進口關稅的提高可能會增加醫療設備的製造成本，這些醫療器材通常包含來自全球供應商的特殊聚合物、滲透性材料和精密工程金屬合金。為此，各公司正在重新審視籌資策略、生產佈局和庫存緩衝，以減輕關稅帶來的利潤壓力。

一些製造商可能會加快推進導管最終組裝回國內的策略，或對國內戰略材料供應商合格，並接受短期工具和驗證方面的投資，以確保長期價格穩定。其他製造商也可能重新設計供應鏈，重點關注關稅分類的變更，並與物流供應商重新談判條款，以抵消不斷上漲的成本。醫療系統和集團採購組織可能會向供應商施壓，要求其提高成本促進因素的透明度，並尋求合約機制來分擔不斷上漲的關稅帶來的負擔，同時確保能夠獲得高性能設備。

除了直接的成本影響外，關稅還有可能透過改變現有跨國供應商相對於本地製造商的成本地位，重塑競爭動態。這可能會促使具備互補能力的供應商進行整合，或為那些能夠在不降低技術性能的前提下提供本土替代方案的靈活型公司創造利基市場機會。最終，關稅的影響將取決於相關人員在成本結構變化的情況下，調整採購方式、對替代材料進行認證以及維持對品質和合規性投資的能力。

深度細分主導的洞察，揭示了產品類型、材料、尺寸、應用和最終用戶環境如何相互作用，從而影響設計優先級和採用管道。

透過對產品、材料、尺寸、應用和最終用戶細分進行詳細分析，可以揭示臨床需求與工程研發的交匯點。在產品差異化方面，診斷導管的特點在於其在血管造影術和壓力監測中的作用，而引導導管則以其增強結構和柔軟的尖端設計為特徵，兼顧支撐性和非侵入性血管介入。微導管提供導絲引導和快速更換選項，這會影響手術流程和配套器械的兼容性。材料包括用於提高柔韌性和耐久性的聚醚嵌段醯胺、用於提高尺寸穩定性和耐熱性的聚醯亞胺以及用於提高潤滑性和低摩擦性的聚四氟乙烯。尺寸分級——1.2F–1.5F、1.6F–2.0F 和 2.1F–2.5F——與解剖通路範圍以及可透過指定管腔輸送的器械複雜程度直接相關。

動脈瘤治療策略包括血管內卷取和血流導向裝置的日益普及。栓塞術使用液體或顆粒狀栓塞劑，需要配套的輸送系統。門診手術中心、醫院和專科診所各自擁有獨特的採購通訊協定。即使在醫院內部，社區和三級醫療機構在病例複雜程度、手術能力和臨床管治也存在差異，這些差異影響著首選器械類型和供應商關係。整合這些因素凸顯了器械配置、臨床適應症和照護現場環境之間的相互依存關係，強調了企業需要根據不同的手術流程和醫療機構的特定要求調整產品系列。

美洲、歐洲、中東和非洲以及亞太地區之間的區域動態和戰略要務的比較將影響商業化和監管方式。

區域動態對監管預期、臨床實務模式和供應鏈物流有顯著影響。在美洲，病患准入模式和以結果為基本契約推動了對具備高效性和可靠性的醫療器材的需求，而分銷網路則更傾向於能夠提供快速回應服務、培訓和售後支援的供應商。在某些市場，複雜的報銷流程和醫院整合進一步影響了採購週期和大型綜合醫療服務網路的議價能力。

在歐洲、中東和非洲，監管集中化和區域協調工作正在影響產品註冊策略和上市後監測要求。各國臨床實務和資源可用性的差異，既為提供高階產品的供應商帶來了機遇，也帶來了挑戰。在亞太地區，對三級醫療中心的快速投資、腦血管疾病盛行率的上升以及手術量的增加，正在推動先進導管技術的快速普及，但分散的採購環境和多樣化的管理體制要求企業採取量身定做的市場進入策略。每個地區在臨床參與、臨床醫生培訓和經銷商合作方面都存在差異，迫使製造商調整其商業化策略，以適應當地的監管時間表、臨床醫生的偏好和物流實際情況。

因此，採取以本地情況為依據的方法，將監管規劃、本地臨床證據生成和適應性經銷夥伴關係相結合，對於持續推廣和長期市場相關性至關重要。

對成熟的全球設備公司、敏捷的創新者和策略製造夥伴進行競爭分析，以確定商業性優勢。

神經血管導管領域的競爭格局既有成熟的器材公司，也有專注於特定技術優勢的專業創新企業。該領域的領導企業通常擁有多層次的產品組合，涵蓋診斷、引導和微導管等器械，並將產品創新與臨床醫生培訓和真實世界資料收集的投入相結合。這些公司強調其擁有完善的品質系統、清晰的監管管道以及全球分銷和服務網路。

規模較小、專注於技術的公司通常透過材料科學的進步、專有塗層或新型製造技術來提升潤滑性、抗扭結性或滲透性，從而實現差異化。關鍵意見領袖（KOL）的敏捷性使得公司能夠快速迭代，並與卓越臨床中心的關鍵意見領袖密切合作，從而為在特定適應症領域儘早應用產品創造機會。隨著整合解決方案能夠提高手術效率並減少器械更換，器械創新者與治療性植入物和栓塞器械製造商之間的合作日益普遍。同時，契約製造製造商和組件夥伴關係也發揮關鍵作用，協助先進聚合物和導管尖端組件的規模化生產和成本最佳化。總而言之，競爭優勢源於技術信譽、臨床證據、供應可靠性以及在醫療機構採購優先事項中提出引人注目的價值主張的能力。

領導者鼓勵採取切實可行的雙軌舉措，以增強供應鏈韌性，加速具有臨床意義的創新，並使商業模式與醫療機構的優先事項保持一致。

產業領導者應採取雙軌策略，在短期營運韌性與持續投資臨床和技術差異化之間取得平衡。目前，他們正在審查關鍵材料的採購和分類，以降低關稅波動帶來的風險，同時加快供應商資格認證計劃，分散地理風險。同時，對庫存管理和需求預測的同步投資將減輕供應鏈衝擊造成的營運中斷，並支持在時間緊迫的神經血管手術期間保持穩定運作。

在策略層面，我們優先進行研發工作，以解決臨床醫生提出的痛點，例如提高在複雜解剖結構中的操作靈活性、增強與新型植入式設備的兼容性，以及減少手術過程中更換步驟的設計。我們投資於上市後資料收集和真實世界證據的生成，以證實臨床價值主張並支持醫保報銷談判。我們加強與臨床中心的合作，進行手術訓練、基於模擬的推廣計畫以及迭代回饋機制，以指導產品改進。最後，我們開發將設備性能與整體手術價值（例如縮短手術時間、降低併發症發生率和提高患者吞吐量）明確掛鉤的商業模式，使供應商的獎勵與機構目標保持一致，並促進產品在不同終端用戶環境中的應用。

採用透明、以證據主導的調查方法，結合臨床醫師訪談、技術評估、監管分析和供應鏈壓力測試，為策略決策提供支援。

調查方法結合了多層次的證據框架，整合了來自臨床醫生、技術評估、監管分析和供應鏈審核的原始資訊。主要見解是透過對介入性神經科、神經介入放射科醫生和採購負責人進行結構化訪談收集的，並輔以與設計工程師和材料科學家的技術諮詢。二級資訊來源包括同行評審的臨床文獻、設備標籤標準和公開的監管文件，這些資料為設備性能和安全性方面的見解提供了背景資訊。供應鏈評估包括繪製材料投入、製造流程和物流節點圖，以識別潛在的弱點和改進機會。

我們的分析方法融合了設備對比分析、材料性能評估以及在關稅和物流中斷情境下對供應鏈配置的壓力測試。我們盡可能地對多個資料流進行三角驗證，以確保研究結果的可靠性。我們將臨床偏好與設計特徵集進行交叉比對，並根據產品開發藍圖評估監管時間表。在整個過程中，我們始終關注潛在的偏差，並透過工程檢驗和臨床醫生的佐證檢驗技術聲明，從而獲得基於實證的實用觀點，為營運決策和產品策略的最佳化提供支援。

整合臨床、技術和營運方面的必要因素，能夠為相關人員明確策略重點，幫助他們確定維持應用和降低風險的關鍵所在。

神經血管導管領域正經歷快速的技術革新、臨床通訊協定的不斷變化以及複雜的供應鏈和法規環境。器械製造商和醫療系統都面臨著雙重挑戰：既要為精細的神經血管介入手術提供高性能解決方案，又要維持穩健且經濟高效的供應鏈。材料創新和精密的導管設計正在拓展手術的可能性，但要真正獲得應用，必須證明其臨床和操作上的優勢能夠引起醫療機構採購負責人和臨床團隊的共鳴。

關稅主導的成本壓力和區域監管差異要求企業積極主動地進行供應鏈和商業化規劃，而那些整合材料策略、積極與臨床醫生互動並掌握本地市場情報的企業將更有能力應對不確定性。透過將產品開發與臨床醫生提出的需求結合、投資於真實世界證據並建立靈活的採購模式，相關人員可以加速產品推廣應用並降低系統性風險。因此，專注於技術卓越、務實執行以及可衡量的臨床和營運成果的這一領域將獲得回報。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 開發生物活性聚合物塗層以減少神經血管導管中的血栓形成
  • 低剖面神經血管導管可改善遠端腦血管的路徑。
  • 將機器人技術和人工智慧驅動的引導系統結合，用於神經介入手術中的精準導管置入
  • 新型雙腔導管設計可在中風治療中同時進行抽吸和支架取出。
  • 增加藥物釋放型技術的投資，以預防顱內支架輔助彈簧圈栓塞術後的再血管再阻塞
  • 重點研發滲透性標記物，以提高神經血管手術中導管尖端的可見性
  • 神經介入手術室改用一次性無菌包裝解決方案，以最大限度降低感染風險
  • 經經皮神經血管通路技術的推廣應用可縮短患者復原時間和住院時間。
  • 監管核准趨勢對下一代神經血管導管器械市場准入的影響
  • 醫療器材製造商與醫療服務提供者合作，最佳化導管材料的生物相容性

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 神經血管導管市場（依產品類型分類）

  • 診斷導管
    • 血管造影術診斷
    • 壓力監測
  • 引導管
    • 加強
    • 軟頭
  • 微導管
    • 附導線
    • 快速交換

9. 按材料分類的神經血管導管市場

  • 聚醚嵌段醯胺
  • 聚醯亞胺
  • 聚四氟乙烯

第10章 神經血管導管市場（依尺寸分類）

  • 1.2F～1.5F
  • 1.6F～2.0F
  • 2.1F～2.5F

第11章 神經血管導管市場（依應用領域分類）

  • 動脈瘤治療
    • 血管內彈簧圈栓塞術
    • 分流裝置
  • 栓塞術
    • 液體栓塞
    • 顆粒栓塞
  • 血栓切除術

第12章 神經血管導管市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
    • 社群
    • 三級醫療
  • 專科診所

第13章 神經血管導管市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 神經血管導管市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國神經血管導管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtronic plc
    • Stryker Corporation
    • Johnson & Johnson Services, Inc.
    • Boston Scientific Corporation
    • Penumbra, Inc.
    • Terumo Corporation
    • MicroVention, Inc.
    • Merit Medical Systems, Inc.
    • Becton, Dickinson and Company
    • WL Gore & Associates, Inc.
Product Code: MRR-A339DAEF9DC3

The Neurovascular Catheters Market is projected to grow by USD 12.45 billion at a CAGR of 12.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.90 billion
Estimated Year [2025] USD 5.51 billion
Forecast Year [2032] USD 12.45 billion
CAGR (%) 12.36%

Framing the critical role of neurovascular catheters in modern endovascular care and the converging clinical, technological, and procurement pressures shaping the field

Neurovascular catheters occupy a pivotal role at the intersection of interventional neurology, endovascular therapy, and acute stroke care. These devices facilitate access, navigation, and delivery of therapeutic agents or implants within cerebral vasculature, enabling procedures ranging from diagnostic angiography to complex aneurysm repair and thrombectomy. Recent advances in microcatheter engineering, refined catheter tip designs, and novel materials have collectively improved deliverability and clinical precision, reducing procedural time and expanding the treatable lesion set. As clinicians push toward less invasive approaches and expanded indications, the importance of catheter performance attributes such as trackability, torque response, and lumen integrity has become paramount.

Clinical pathways and hospital systems are increasingly structured around rapid, protocol-driven interventions for acute neurovascular events, which places greater emphasis on devices that support swift access and reliable performance under emergency conditions. At the same time, the convergence of device innovation, regulatory scrutiny, and payer-driven quality metrics reshapes procurement priorities and vendor relationships. Consequently, manufacturers and health systems must balance technical innovation with manufacturability, sterilization compatibility, and supply resilience. In this dynamic environment, a precise understanding of product differentiation, material trade-offs, and procedural requirements is essential for stakeholders across research and development, clinical leadership, and commercial operations.

This introduction establishes the conceptual frame for subsequent sections by highlighting the technological drivers, clinical imperatives, and system-level pressures that will inform strategic decisions for device designers, hospital supply leaders, and policy stakeholders.

Understanding the pivotal technological, clinical, and regulatory transformations reshaping neurovascular catheter design, adoption dynamics, and supplier value propositions

The neurovascular device landscape is experiencing several transformative shifts driven by technological refinement, procedural standardization, and evolving reimbursement expectations. Engineers are focusing on hybrid constructions that combine flexibility with column strength, enabling long, tortuous navigations without sacrificing support for device delivery. Concurrently, the proliferation of adjunctive devices-such as flow diverters and specialized embolic agents-has altered catheter function requirements, creating demand for differentiated microcatheters optimized for compatibility with emerging therapies.

Clinical pathways are trending toward protocolization of stroke and aneurysm responses, which prioritizes devices that minimize setup and exchange time. This shift incentivizes manufacturers to optimize delivery systems for rapid access, reduce device exchanges, and enhance radiopacity for more efficient fluoroscopic control. Regulatory frameworks are also tightening around post-market surveillance and product traceability, prompting firms to invest in quality systems and data capture mechanisms that demonstrate real-world performance and safety. Financially, health systems are increasingly evaluating total procedural cost and outcome metrics, which encourages vendors to articulate value propositions that go beyond unit price to include device reliability, reduced complication rates, and support for bundled care models.

Taken together, these shifts create a landscape in which innovation is measured not only in technical novelty but also in demonstrable clinical and operational impact. Vendors that can integrate materials science advances with clear clinical utility and supply chain robustness will be best positioned to influence adoption pathways and long-term clinical practice patterns.

Assessing how the introduction of United States tariff adjustments in 2025 will alter sourcing strategies, production footprints, and competitive dynamics across the supply chain

Tariff policy changes in the United States for 2025 present an inflection point for manufacturers, distributors, and hospital purchasing organizations that rely on complex, multi-tiered supply chains. Increased import duties on certain medical components can elevate production costs for devices that incorporate specialized polymers, radiopaque materials, or precision-engineered metal alloys sourced from global suppliers. In response, organizations will reassess sourcing strategies, production footprints, and inventory buffers to mitigate exposure to tariff-driven margin pressure.

Some manufacturers may accelerate strategies to onshore the final assembly of catheters or to qualify domestic suppliers for strategic materials, accepting short-term investment in tooling and validation to secure longer-term pricing stability. Others may pursue tariff classification reviews and supply chain redesigns that emphasize consolidation of shipments and renegotiation of commercial terms with logistics providers to offset cost increases. Health systems and group purchasing organizations will likely pressure vendors for greater transparency on cost drivers and pursue contract mechanisms that share the burden of incremental duties while preserving access to high-performance devices.

Beyond direct cost implications, tariff measures can reshape competitive dynamics by altering the relative cost positions of established multinational suppliers versus regionally based manufacturers. This may spur consolidation among suppliers with complementary capabilities, or create niche opportunities for agile firms that can provide onshore alternatives without compromising on technical performance. Ultimately, tariff effects will be mediated by the capacity of stakeholders to adapt procurement practices, qualify alternative materials, and sustain investments in quality and regulatory compliance amid shifting cost structures.

Deep segmentation-driven insights revealing how product type, materials, sizes, applications, and end-user settings interact to shape design priorities and adoption pathways

A granular view of product, material, size, application, and end-user segmentation illuminates where clinical demand and engineering effort converge. When considering product distinctions, diagnostic catheters are characterized by roles in angiographic imaging and pressure monitoring; guiding catheters are differentiated by reinforced constructions and soft-tip designs that balance support and atraumatic vessel engagement; and microcatheters present choices between over-the-wire systems and rapid exchange formats that influence procedural workflow and companion device compatibility. Material selection plays a central role in device behavior, with polyether block amide offerings prized for flexibility and durability, polyimide used where dimensional stability and heat resistance are required, and polytetrafluoroethylene selected for its lubricity and low friction. Size gradations ranging from 1.2F to 1.5F, 1.6F to 2.0F, and 2.1F to 2.5F correlate directly with the scope of anatomical access and the complexity of devices that can be delivered through a given lumen.

Application-based segmentation further clarifies clinical trajectories: aneurysm treatment strategies encompass endovascular coiling and the growing use of flow diversion devices, embolization procedures may employ liquid or particle embolic agents requiring compatible delivery systems, and thrombectomy tools demand catheters capable of efficient clot engagement and aspiration. The distribution of procedural volume across end users influences product development and commercialization strategies, with ambulatory surgery centers, hospitals, and specialty clinics each presenting distinctive purchasing protocols. Within hospitals, community and tertiary care facilities diverge in case complexity, procedural throughput, and clinical governance, shaping preferred device profiles and supplier relationships. Synthesizing these segmentations highlights the interdependence between device configuration, clinical indication, and point-of-care environment, and underscores the imperative for companies to align product portfolios with nuanced procedural and institutional requirements.

Comparative regional dynamics and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that dictate commercialization and regulatory approaches

Regional dynamics exert a substantial influence on regulatory expectations, clinical practice patterns, and supply chain logistics. In the Americas, patient access models and an emphasis on outcomes-based contracting are driving demand for devices that demonstrate procedural efficiency and reliability, while distribution networks favor vendors that can provide rapid service, training, and post-market support. Reimbursement complexity and hospital consolidation in some markets further shape purchasing timelines and the negotiation leverage of large integrated delivery networks.

Within Europe, the Middle East & Africa, regulatory alignment driven by centralized authorities and regional harmonization efforts impacts product registration strategies and post-market surveillance requirements. Clinical practice variability across countries and variable resource availability create both opportunities and constraints for vendors offering premium designs. In Asia-Pacific, rapid investment in tertiary care centers, growing prevalence of cerebrovascular disease, and increasing procedural volumes are motivating faster adoption of advanced catheter technologies, though fragmented procurement environments and diverse regulatory regimes require tailored market entry approaches. Each region presents distinct paths for clinical engagement, clinician training, and distributor partnerships, and manufacturers must calibrate commercialization strategies that reflect local regulatory timelines, clinician preferences, and logistical realities.

Consequently, a regionally informed approach that integrates regulatory planning, local clinical evidence generation, and adaptive distribution partnerships will be essential for sustained adoption and long-term market relevance.

Analyzing competitive strengths across established global device companies, agile innovators, and strategic manufacturing partners that determine commercial advantage

Competitive landscapes in neurovascular catheters are shaped by a mixture of established device firms and specialized innovators focusing on narrow technical advantages. Leaders in the space typically maintain multi-tiered portfolios that span diagnostic, guiding, and microcatheter offerings and that pair product innovation with investments in clinician training and real-world data collection. These companies emphasize robust quality systems, clear regulatory pathways, and the capacity to support global distribution and service networks.

Smaller, technology-focused firms often differentiate by advancing materials science, proprietary coatings, or novel manufacturing techniques that improve lubricity, kink resistance, or radiopacity. Their agility allows for rapid iteration and close collaboration with key opinion leaders in clinical centers of excellence, creating early adoption opportunities for niche indications. Partnerships between device innovators and makers of therapeutic implants or embolic agents are increasingly common, as integrated solutions enhance procedural efficiency and reduce device exchanges. In parallel, contract manufacturers and component specialists play critical roles by enabling scale-up and cost optimization for advanced polymer and catheter tip assemblies. Overall, competitive advantage stems from a combination of technical credibility, clinical evidence, supply reliability, and the ability to present compelling value in the context of institutional procurement priorities.

Practical, dual-track recommendations for leaders to strengthen supply resilience, accelerate clinically meaningful innovation, and align commercial models with institutional priorities

Industry leaders should adopt a dual-track strategy that balances near-term operational resilience with sustained investment in clinical and technological differentiation. In the immediate term, reassess sourcing and classification of critical materials to blunt exposure to tariff volatility while accelerating supplier qualification programs that diversify geographic risk. Parallel investments in inventory management and demand sensing will reduce the operational disruption from supply chain shocks and support consistent availability in time-sensitive neurovascular procedures.

Strategically, prioritize R&D that addresses clinician-identified pain points such as improved navigability in tortuous anatomies, compatibility with new implantable devices, and designs that reduce exchange steps during procedures. Invest in post-market data capture and real-world evidence generation to substantiate claims of clinical value and to support reimbursement dialogues. Strengthen collaborations with clinical centers for procedural training, simulation-based adoption programs, and iterative feedback loops that inform product refinement. Finally, build commercial models that articulate total procedural value-linking device performance to reduced procedure time, lower complication rates, and improved patient throughput-to align vendor incentives with institutional goals and accelerate uptake across diverse end-user settings.

Transparent and evidence-driven research methodology combining clinician interviews, technical evaluations, regulatory analysis, and supply chain stress-testing to support strategic decisions

The research approach combined a multi-tiered evidence framework that synthesizes primary clinician inputs, engineering assessments, regulatory analysis, and supply chain audits. Primary insights were gathered through structured interviews with interventional neurologists, neurointerventional radiologists, and procurement leaders, supplemented by technical consultations with design engineers and materials scientists. Secondary sources encompassed peer-reviewed clinical literature, device labeling standards, and publicly accessible regulatory filings, which informed device performance context and safety considerations. Supply chain assessments included mapping of material inputs, manufacturing steps, and logistics nodes to identify potential vulnerability points and resilience opportunities.

Analytical methods incorporated comparative device profiling, materials property evaluation, and scenario-based stress testing of supply chain configurations under tariff and logistical disruption scenarios. Where possible, triangulation across data streams ensured robustness of findings: clinical preferences were cross-referenced with design feature sets, and regulatory timelines were evaluated against product development roadmaps. Throughout the process, attention was paid to potential bias and to the validation of technical claims through engineering verification and clinician corroboration, yielding a pragmatic and evidence-grounded perspective that supports operational decision-making and product strategy refinement.

Synthesis of clinical, technical, and operational imperatives that conclude with strategic clarity on where stakeholders must focus to sustain adoption and reduce risk

The neurovascular catheter landscape is defined by rapid technical evolution, shifting clinical protocols, and an increasingly complex supply and regulatory environment. Device makers and health systems alike face the dual imperatives of delivering high-performance solutions for delicate cerebrovascular interventions while maintaining resilient, cost-effective supply chains. Material innovations and refined catheter architectures are expanding procedural capabilities, yet adoption hinges on demonstrable clinical benefits and operational advantages that resonate with institutional purchasers and clinical teams.

Tariff-driven cost pressures and regional regulatory subtleties demand proactive supply chain and commercialization planning, and companies that integrate materials strategy, clinician collaboration, and regional market intelligence will be best positioned to navigate uncertainty. By aligning product development with clinician-identified needs, investing in real-world evidence, and building flexible sourcing models, stakeholders can both accelerate adoption and reduce systemic risk. The combined result is a field that rewards technical excellence paired with pragmatic execution and an orientation toward measurable clinical and operational outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Development of bioactive polymer coatings to reduce thrombogenicity in neurovascular catheters
  • 5.2. Adoption of low-profile neurovascular catheters to improve access in distal cerebral vasculature
  • 5.3. Integration of robotics and AI-driven guidance systems for precise catheter placement in neurointerventions
  • 5.4. Emergence of dual-lumen catheter designs enabling simultaneous aspiration and stent retrieval in stroke treatment
  • 5.5. Growing investment in drug-eluting technologies to prevent restenosis after intracranial stent-assisted coiling
  • 5.6. Focus on developing radiopaque markers for enhanced visualization of catheter tip during neurovascular procedures
  • 5.7. Shift towards single-use sterile packaging solutions to minimize infection risk in neurointerventional suites
  • 5.8. Expansion of percutaneous neurovascular access techniques reducing patient recovery times and hospital stays
  • 5.9. Regulatory approval trends influencing market entry of next-generation neurovascular catheter devices
  • 5.10. Collaborations between device manufacturers and healthcare providers to optimize catheter material biocompatibility

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurovascular Catheters Market, by Product Type

  • 8.1. Diagnostic Catheters
    • 8.1.1. Angiographic Diagnostic
    • 8.1.2. Pressure Monitoring
  • 8.2. Guiding Catheters
    • 8.2.1. Reinforced
    • 8.2.2. Soft Tip
  • 8.3. Microcatheters
    • 8.3.1. Over The Wire
    • 8.3.2. Rapid Exchange

9. Neurovascular Catheters Market, by Material

  • 9.1. Polyether Block Amide
  • 9.2. Polyimide
  • 9.3. Polytetrafluoroethylene

10. Neurovascular Catheters Market, by Size

  • 10.1. 1.2F To 1.5F
  • 10.2. 1.6F To 2.0F
  • 10.3. 2.1F To 2.5F

11. Neurovascular Catheters Market, by Application

  • 11.1. Aneurysm Treatment
    • 11.1.1. Endovascular Coiling
    • 11.1.2. Flow Diversion Devices
  • 11.2. Embolization Procedures
    • 11.2.1. Liquid Embolization
    • 11.2.2. Particle Embolization
  • 11.3. Thrombectomy

12. Neurovascular Catheters Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Hospitals
    • 12.2.1. Community
    • 12.2.2. Tertiary Care
  • 12.3. Specialty Clinics

13. Neurovascular Catheters Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Neurovascular Catheters Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Neurovascular Catheters Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtronic plc
    • 16.3.2. Stryker Corporation
    • 16.3.3. Johnson & Johnson Services, Inc.
    • 16.3.4. Boston Scientific Corporation
    • 16.3.5. Penumbra, Inc.
    • 16.3.6. Terumo Corporation
    • 16.3.7. MicroVention, Inc.
    • 16.3.8. Merit Medical Systems, Inc.
    • 16.3.9. Becton, Dickinson and Company
    • 16.3.10. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR CATHETERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANGIOGRAPHIC DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PRESSURE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REINFORCED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SOFT TIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY OVER THE WIRE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY RAPID EXCHANGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYETHER BLOCK AMIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYIMIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.2F TO 1.5F, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 1.6F TO 2.0F, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY 2.1F TO 2.5F, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ENDOVASCULAR COILING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY FLOW DIVERSION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY LIQUID EMBOLIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY PARTICLE EMBOLIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY THROMBECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COMMUNITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY GUIDING CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY SIZE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY ANEURYSM TREATMENT, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION PROCEDURES, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE NEUROVASCULAR CATHETERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE NEUROVASCULAR CATHET